Specialty Pharmacy
July 21, 2021
Contemporary Developments in MET-Selective Kinase Inhibitors in Advanced Non–Small-Cell Lung Cancer
MET-selective kinase inhibitors have become available for the treatment of NSCLC in recent years and have displayed remarkable efficacy in clinical studies to date.July 21, 2021
Biologic Therapy for Eosinophilic Asthma
May 20, 2021
Researchers Look for Drugs That Keep HIV Latent
March 18, 2021
Biosimilar IV and SC Trastuzumab in Clinical Practice
February 22, 2021
Managing Breast Cancer During Pregnancy
February 22, 2021
Polymorphism Linked to Survival in Non-Small Cell Lung Cancer
February 22, 2021
Specialty Pharmacy’s Impact on RA Therapy Adherence
January 22, 2021
Net Spending on Specialty Pharmaceuticals Surging
Copyright © 2000 - 2021 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.